PFG Private Wealth Management’s AbbVie ABBV Stock Holding History

PFG Private Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-12	Closed	-$2.19K	–	242
2024 Q1	$2.19K	Hold	12	–	–	﹤0.01%	194
2023 Q4	$1.86K	Hold	12	–	–	﹤0.01%	199
2023 Q3	$1.79K	Sell	12 -589	-98%	-$86.5K	﹤0.01%	242
2023 Q2	$81K	Buy	601 +276	+85%	+$40.5K	0.05%	133
2023 Q1	$51.8K	Sell	325 -2,172	-87%	-$332K	0.03%	149
2022 Q4	$404K	Sell	2,497 -46	-2%	-$7.05K	0.25%	27
2022 Q3	$341K	Buy	2,543 +1,708	+205%	+$245K	0.22%	29
2022 Q2	$128K	Sell	835 -248	-23%	-$37.9K	0.07%	79
2022 Q1	$176K	Buy	1,083 +1,071	+8,925%	+$156K	0.09%	67
2021 Q4	$2K	Hold	12	–	–	﹤0.01%	283
2021 Q3	$1K	Buy	+12	New	+$1.37K	﹤0.01%	286

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PFG Private Wealth Management's ABBV Position: Q2 2024 in Review

PFG Private Wealth Management sold out of AbbVie (ABBV) in Q2 2024, closing a stake of 12 shares — an estimated $2.19K sold.

PFG Private Wealth Management first reported a position in ABBV in Q3 2021 and held it in 11 quarters. The position peaked at $404K in Q4 2022. 3,364 funds tracked by Wall St. Rank hold ABBV as of Q2 2024.

PFG Private Wealth Management reported no remaining AbbVie position as of Q2 2024 after selling out during the quarter.
PFG Private Wealth Management sold 12 AbbVie shares in Q2 2024, an estimated $2.19K.
PFG Private Wealth Management first reported a position in AbbVie in Q3 2021 and held it in 11 quarters.
PFG Private Wealth Management's AbbVie position peaked at $404K in Q4 2022.
3,364 funds tracked by Wall St. Rank held AbbVie as of Q2 2024.

Based on PFG Private Wealth Management's 13F filing for Q2 2024, filed 15 Jul 2024.